JUAN FRANCISCO ASCASO GIMILIO-rekin lankidetzan egindako argitalpenak (9)

2021

  1. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  3. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2017

  1. The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

    Diabetologia, Vol. 60, Núm. 9, pp. 1801-1812

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

  2. Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia

    European Journal of Clinical Investigation, Vol. 46, Núm. 7, pp. 636-642

  3. Unsaturated oral fat load test improves glycemia, insulinemia and oxidative stress status in nondiabetic subjects with abdominal obesity

    PLoS ONE, Vol. 11, Núm. 8

2014

  1. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis

    Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336